Status:
COMPLETED
Longitudinal MRI Assessment in Patients With Diffuse Low-grade Gliomas
Lead Sponsor:
University Hospital, Montpellier
Conditions:
Low-grade Glioma
Eligibility:
All Genders
18+ years
Brief Summary
Retrospective longitudinal follow-up in patients with diffuse low-grade glioma with multimodal MRI assessment
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Initial WHO grade II
- At least 3 exploitable MRI each including a morphologic FLAIR sequence and perfusion imaging
- Exclusion criteria:
- Major protected person ( trusteeship, curatorship, justice safeguard)
Exclusion
Key Trial Info
Start Date :
March 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 30 2020
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04346472
Start Date
March 1 2016
End Date
January 30 2020
Last Update
April 16 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Uhmontpellier
Montpellier, France, 34295